CRISPR-Cas9 mediated capsule gene silencing in Escherichia coli
Novelty in Biomedicine. 2018; 16 (4): 162-166
em Inglês
| IMEMR
| ID: emr-206569
ABSTRACT
Background:
Genomic engineering of Escherichia coli is applied to design and produce recombinant proteins as the new drugs. The aim of this study was to CRISPR-Cas9 mediated capsule gene silencing in E. coli
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Novelty Biomed.
Ano de publicação:
2018
Similares
MEDLINE
...
LILACS
LIS